A detailed history of Ieq Capital, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 8,032 shares of VCYT stock, worth $219,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,032
Previous 14,657 45.2%
Holding current value
$219,434
Previous $580,000 58.97%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$29.65 - $46.14 $196,431 - $305,677
-6,625 Reduced 45.2%
8,032 $238,000
Q4 2024

Jan 31, 2025

BUY
$31.92 - $44.4 $467,851 - $650,770
14,657 New
14,657 $580,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $1.96B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.